Matthew Gall - 11 Oct 2021 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Chief Financial Officer
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
11 Oct 2021
Net transactions value
+$88,883
Form type
4
Filing time
12 Oct 2021, 20:02:52 UTC
Previous filing
25 Jun 2021
Next filing
28 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITOS Common Stock Options Exercise $88,883 +14,429 +289% $6.16 19,429 11 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (right to buy) Options Exercise $0 -14,429 -25% $0.000000 42,388 11 Oct 2021 Common Stock 14,429 $6.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
F2 One-fourth of the shares subject to the stock option vested on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.